Liu T T, Hsiao K J, Lu S F, Wu S J, Wu K F, Chiang S H, Liu X Q, Chen R G, Yu W M
Institute of Biochemistry, National Yang-Ming University, Taipei, Taiwan.
Hum Mutat. 1998;11(1):76-83. doi: 10.1002/(SICI)1098-1004(1998)11:1<76::AID-HUMU12>3.0.CO;2-W.
Hyperphenylalaninemia (HPA) may be caused by deficiency of phenylalanine hydroxylase or tetrahydrobiopterin (BH4), the essential cofactor for the aromatic amino acid hydroxylases. 6-Pyruvoyl-tetrahydropterin synthase (PTPS) deficiency is a major cause of BH4 deficient HPA. In this study, seven single base mutations at nucleotides 73 (C>G), 155 (A>G), 166 (G>A), 209 (T>A), 259 (C>T), 286 (G>A), and 317 (C>T) on PTPS cDNA were detected in Chinese PTPS-deficient HPA by polymerase chain reaction and solid phase DNA sequencing. These nucleotide alterations result in R25G, N52S, V56M, V70D, P87S, D96N, and T106M amino acid substitutions, respectively. The R25G, V56M, V70D, and T106M were novel mutations found in PTPS gene. By analysis of 38 PTPS mutant alleles from 19 unrelated Chinese PTPS-deficient HPA families, the allele frequency of these mutations in Chinese PTPS-deficient HPA were determined to be approximately 5.3% (R25G), 34.2% (N52S), 7.9% (V56M), 2.6% (V70D), 36.8% (P87S), 7.9% (D96N), and 2.6% (T106M), respectively. Two common mutations, N52S and P87S, were found to account for 71% of the Chinese PTPS mutant alleles. The N52S mutation accounts for 48% of the southern Chinese PTPS mutation, but only one (9%) of the northern Chinese PTPS mutant allele was found to be N52S, which suggested that the N52S mutation might be southern Chinese. Clinically, the V56M mutation was found to associate with the mild form of PTPS deficiency. However, the R25G, N52S, P87S, and D96N were found mainly in the patients with severe clinical symptom. Using polymerase chain reaction-based mutation analysis, a fetus at risk of PTPS deficiency was diagnosed prenatally to be a carrier of N52S mutation.
高苯丙氨酸血症(HPA)可能由苯丙氨酸羟化酶或四氢生物蝶呤(BH4)缺乏引起,BH4是芳香族氨基酸羟化酶的必需辅助因子。6-丙酮酰四氢蝶呤合酶(PTPS)缺乏是BH4缺乏型HPA的主要原因。在本研究中,通过聚合酶链反应和固相DNA测序,在中国PTPS缺乏型HPA患者中检测到PTPS cDNA上核苷酸73(C>G)、155(A>G)、166(G>A)、209(T>A)、259(C>T)、286(G>A)和317(C>T)处的7个单碱基突变。这些核苷酸改变分别导致R25G、N52S、V56M、V70D、P87S、D96N和T106M氨基酸替代。R25G、V56M、V70D和T106M是在PTPS基因中发现的新突变。通过对来自19个不相关的中国PTPS缺乏型HPA家庭的38个PTPS突变等位基因进行分析,确定这些突变在中国PTPS缺乏型HPA中的等位基因频率分别约为5.3%(R25G)、34.2%(N52S)、7.9%(V56M)、2.6%(V70D)、36.8%(P87S)、7.9%(D96N)和2.6%(T106M)。发现两个常见突变N52S和P87S占中国PTPS突变等位基因的71%。N52S突变占中国南方PTPS突变的48%,但在中国北方PTPS突变等位基因中仅发现1个(9%)是N52S,这表明N52S突变可能在中国南方。临床上,发现V56M突变与PTPS缺乏的轻度形式相关。然而,R25G、N52S、P87S和D96N主要见于临床症状严重的患者。通过基于聚合酶链反应的突变分析,产前诊断出一名有PTPS缺乏风险的胎儿为N52S突变携带者。